Low FNDC5/Irisin expression is associated with aggressive phenotypes in gastric cancer.
Xu L, Ye Y, Sun Y, Zhong W, Chi L, Lin Y, Liu H, Li S, Chen H, Li C, Lin Y, Wang Q, Xue F, Lin Y.
Xu L, et al. Among authors: zhong w.
Front Pharmacol. 2022 Oct 28;13:981201. doi: 10.3389/fphar.2022.981201. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36386179
Free PMC article.